Literature DB >> 11887973

Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics.

V Frykman1, M Frick, M Jensen-Urstad, J Ostergren, M Rosenqvist.   

Abstract

OBJECTIVE: This prospective study was designed to investigate the differences between asymptomatic versus symptomatic arrhythmia as well as left ventricular dysfunction in a consecutive population of patients with persistent atrial fibrillation.
DESIGN: A total of 282 consecutive outpatients referred with persistent atrial fibrillation formed the study population. A structured medical history was obtained. A two-dimensional transthoracic echocardiography to assess the left ventricular function and a 24-h electrocardiogram (ECG) recording were performed. Irregularity of the heart rhythm was analysed with heart rate variability (HRV) in the time domain as well as maximum and minimum heart rate and the longest pause.
SETTING: Three university hospitals.
RESULTS: The mean age of the patients was 69 years and the mean duration of atrial fibrillation was 7 months. The prevalence of symptomatic patients was 68%, while 32% had no symptoms from atrial fibrillation, left ventricular dysfunction was observed in 20%. Asymptomatic subjects had more often lone atrial fibrillation than those with symptoms. Valvular heart disease was an independent predictor of symptoms while male gender, ischaemic heart disease and a high heart rate were independent predictors of impaired left ventricular function.
CONCLUSION: Valvular heart disease is related to symptoms in persistent atrial fibrillation. Ischaemic heart disease, male gender and a high heart rate are more common in patients with impaired left ventricular function. Compromised left ventricular function does, occur also in asymptomatic subjects underlining the importance of a careful investigation including echocardiography in all subjects with persistent atrial fibrillation.

Entities:  

Mesh:

Year:  2001        PMID: 11887973     DOI: 10.1046/j.1365-2796.2001.00893.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  8 in total

Review 1.  [Atrial fibrillation].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

2.  Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation.

Authors:  A Nergårdh; M Frick
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

Review 3.  Subcutaneouscardiac Rhythm Monitors: A Comprehensive Review.

Authors:  Gaurav Aggarwal; Saurabh Aggarwal; Venkata Alla; Bharat Narasimhan; Kyungmoo Ryu; Courtney Jeffery; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2021-02-28

4.  Prediction models for atrial fibrillation applicable in the community: a systematic review and meta-analysis.

Authors:  Jelle C L Himmelreich; Lieke Veelers; Wim A M Lucassen; Renate B Schnabel; Michiel Rienstra; Henk C P M van Weert; Ralf E Harskamp
Journal:  Europace       Date:  2020-05-01       Impact factor: 5.214

Review 5.  Large-scale screening studies for atrial fibrillation - is it worth the effort?

Authors:  J Engdahl; M Rosenqvist
Journal:  J Intern Med       Date:  2021-01-07       Impact factor: 8.989

6.  Associations of Atrial Fibrillation with Mild Cognitive Impairment and Dementia: An Investigation Using SPRINT Research Materials.

Authors:  Aniqa B Alam; Ambar Kulshreshtha; Linzi Li; Vinita Subramanya; Alvaro Alonso
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

7.  Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial.

Authors:  Steven B Uittenbogaart; Nicole Verbiest-van Gurp; Petra M G Erkens; Wim A M Lucassen; J André Knottnerus; Bjorn Winkens; Henk C P M van Weert; Henri E J H Stoffers
Journal:  Trials       Date:  2015-10-23       Impact factor: 2.279

8.  Frequency of arrhythmia symptoms and acceptability of implantable cardiac monitors in Hemodialysis patients.

Authors:  Naya El Hage; Bernard G Jaar; Alan Cheng; Chloe Knight; Elena Blasco-Colmenares; Luis Gimenez; Eliseo Guallar; Tariq Shafi
Journal:  BMC Nephrol       Date:  2017-10-10       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.